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Entropic reactiontory drugs (NSAIDs) represent non-speciﬁc inhibitors of the cycloxygenase
pathway of inﬂammation, and therefore an understanding of the interaction process of the drugs with
membrane phospholipids is of high relevance. We have studied the interaction of the NSAIDs with
phospholipid membranes made from dimyristoylphosphatidylcholine (DMPC) by applying Fourier-transform
infrared spectroscopy (FTIR), Förster resonance energy transfer spectroscopy (FRET), differential scanning
calorimetry (DSC) and isothermal titration calorimetry (ITC). FTIR data obtained via attenuated total
reﬂectance (ATR) show that the interaction between DMPC and NSAIDs is limited to a strong interaction of
the drugs with the phosphate region of the lipid head group. The FTIR transmission data furthermore are
indicative of a strong effect of the drugs on the hydrocarbon chains inducing a reduction of the chain–chain
interactions, i.e., a ﬂuidization effect. Parallel to this, from the DSC data beside the decrease of Tm a reduction
of the peak height of the melting endotherm connected with its broadening is observed, but leaving the
overall phase transition enthalpy constant. Additionally, phase separation is observed, inducing the
formation of a NSAID-rich and a NSAID-poor phase. This is especially pronounced for Diclofenac. Despite the
strong inﬂuence of the drugs on the acyl chain moiety, FRET data do not reveal any evidence for drug
incorporation into the lipid matrix, and ITC measurements performed do not exhibit any heat production due
to drug binding. This implies that the interaction process is governed by only entropic reactions at the lipid/
water interface.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionThe nonsteroidal anti-inﬂammatory drugs (NSAIDs) are a wide
non-chemically related group of compounds that are also called
“aspirin-like drugs” for sharing similar therapeutic actions. They have
been used since the introduction of acetylsalicylic acid (Aspirin) in
1899 [1]. NSAIDs are a large family of compounds classiﬁed into
several subgroups, based on their chemical structure, like salicylates
(Aspirin, Diﬂunisal), phenylacetic acids (Diclofenac), indoles (Indo-
methacin), oxicams (Piroxicam, Meloxicam), pyrazoles (Phenylbuta-
zone) and sulphonanilides (Nimesulide) [2]. Despite their structural
diversity, NSAIDs share most of the therapeutic actions as well as side-
effects. Within the most widely prescribed and recognized drugs,ory drugs; DMPC, dimyristoyl-
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burg).
ll rights reserved.Ibuprofen, Naproxen and Diclofenac are well-established NSAIDs,
exhibiting anti-inﬂammatory, analgesic, antithrombotic and antipyre-
tic properties [3]. Since 1974, Diclofenac is widely used in the long-
term treatment of degenerative diseases. Some of its associated side-
effects are hepatoxicity and liver injury [4]. Naproxen is used for the
treatment of mild to moderate pain and fever. The most common side
effects from Naproxen are headaches, dizziness, abdominal pain,
nausea, and shortness of breath. Naproxen is associated with an
increase in the risk to suffer heart attack and malignant effect on
mucosal hydrophobicity [5]. One severe challenge encountered with
the use of NSAIDs is their little gastrointestinal tolerability [6–9].
In most countries, Ibuprofen is freely available which allows self-
medication. It has a wide range of side-effects including cardiovas-
cular [10], renal and hepatic damage associated with long-time
treatments [11]. They are also extensively medicated for rheumatoid
arthritis, osteoarthritis, andmusculoskeletal disorders. Recently, some
of the NSAIDs have emerged as part of a new cancer chemotherapeutic
and chemopreventive therapy [12,13].
The common mechanism of action of all NSAIDs is the inhibition
of the cyclooxygenase (COX) enzyme. The COX pathway converts
arachidonic acid inprostaglandins and thromboxans,which contribute
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are at least two COX isoenzymes. The isoforms are called cycloox-
ygenase 1 and 2, and possess distinct enzymatic activities [16]. COX-1
is expressed constitutively in most tissues types and it is involved in
the synthesis of prostaglandins which protect the stomach lining,
intestine and kidney fromdamage. COX-2 is only expressed in a limited
number of cell types and contributes among other activities to the
inﬂammation processes in cells like ﬁbroblasts, macrophages and
monocytes [17]. Because of the high degree of structural similarity,
most of the NSAIDs are non-selective inhibitors of COX-2 [18]. Most
serious and sometimes fatal side-effects are gastrointestinal damage
including ulceration and haemorrhage, renal toxicity, inhibition of the
platelet aggregation that can lead to coagulation disorders which are
side effects of non-selective (non-selective) COX-1 inhibition [19].
Additionally, studies have shown alternative COX-independent
mechanisms of action inducing local ulcerations in the gastrointestinal
tract [20]. These ﬁndings suggest the possibility of a direct membrane
activity.
Artiﬁcial membranes are commonly used as a model for natural
membranes to study drug–membrane interactions. The major
constituents of themembrane are phospholipids. They are responsible
for several features of the bilayer like stability and semi-permeable
properties. Major lipidic components of eucaryotic cell membranes
are phosphatidylcholines. The interactions of the NSAIDs with
phospholipids can change the physicochemical properties of the
membranes, which may be essential to understand the dynamics of
the mechanism of action. The aim of this study was to investigate the
interactions between dimyristoyl-phosphatidyl choline (DMPC) lipo-
somes and three NSAIDs (Ibuprofen, Naproxen and Diclofenac as
sodium salts). The results describe the molecular details of these
interactions and the consequences for the membranes properties, by
using Fourier-transform infrared spectroscopy (FTIR) in transmission
and with attenuated total reﬂection (ATR), differential scanning
calorimetry (DSC), isothermal titration calorimetry (ITC), and Förster
resonance energy transfer spectroscopy (FRET).
2. Materials and methods
2.1. Lipid sample preparation
The lipid samples were prepared as aqueous dispersions at varying
buffer (20 mMHEPES pH 7.4) content, depending on the sensitivity of
the technique: 0.1 mM for the FRET-, 0.4 mM for the DSC-, and 20–
40 mM for the FTIR-experiments. In all cases, the lipids were
suspended directly in buffer, sonicated, and temperature-cycled
several times between 5 and 70 °C and then stored at 4 °C before
measurement. The drugs were dissolved in buffer and added to the
phospholipid liposomes at the given molar ratios, and the measure-
ments were done with these freshly prepared dispersions.
2.2. Fourier-transform infrared spectroscopy
The infrared spectroscopic measurements were performed on an
IFS-55 spectrometer (Bruker, Karlsruhe, Germany). For phase transi-
tion measurements, the lipid samples were placed in a CaF2 cuvette
with a 12.5 μm Teﬂon spacer. Temperature-scans were performed
automatically between a low initial temperature (−20 °C to +10 °C)
and 70 °C with a heating rate of 0.6 °C min−1. For measurement of
hydrated lipid samples, these were spread on a ATR Ge plate, and free
water was evaporated. Every 3 °C, 50 interferograms were accumu-
lated, apodized, Fourier-transformed, and converted to absorbance
spectra.
For the evaluation of the gel to liquid crystalline phase behaviour,
the peak position of the symmetric stretching vibration of the
methylene band νs(CH2) around 2850 cm−1 was taken, which is a
sensitive marker of lipid order [21,22]. Furthermore, vibrational bandsfrom the interface region (ester carbonyl stretch around 1725 to
1740 cm−1), and the head group (antisymmetric stretch at 1260 to
1220 cm−1, the choline group around 1100 to 1000 cm−1, and the N–
H stretching band at 1000 to 950 cm−1) were analyzed. The
instrumental wavenumber resolution is better than 0.02 cm−1, the
wavenumber reproducibility in repeated scans is better than 0.1 cm−1.
2.3. Differential scanning calorimetry
Differential scanning calorimetry (DSC) measurements were
performed with a VP-DSC calorimeter (MicroCal, Inc., Northampton,
MA, USA) at a heating and cooling rate of 1 °Cmin−1. The DSC samples
were prepared by dispersing a known amount (5.6mM) in 10mMPBS
buffer at pH 7.4. The samples were hydrated in the liquid crystalline
phase by vortexing. Prior to the measurements the DSC samples were
stored for a deﬁned time at 4 °C (see text). The measurements were
performed in the temperature interval from5 °C to 65 °C. In the ﬁgures
only the temperature range is shown where phase transitions were
observed. Five consecutive heating and cooling scans checked the
reproducibility of the DSC experiments of each sample [23]. The
accuracy of the DSC experiments was ±0.1 °C for the main phase
transition temperatures and ±1 kJ mol−1 for the main phase
transition enthalpy. The DSC data were analyzed using the Origin
software. The phase transition enthalpy was obtained by integrating
the area under the heat capacity curve [24].
2.4. Isothermal titration calorimetry
Microcalorimetric experiments of drug binding to DMPC were
performed on a MCS isothermal titration calorimeter (Microcal Inc.,
Northampton, MA, USA) at various temperatures. The phospholipid
samples at a concentration of 0.05 to 0.15 mM – prepared as described
above –were ﬁlled into themicrocalorimetric cell (volume 1.3ml) and
the drugs in the concentration range 0.5 to 5 mM into the syringe
compartment (volume 100 μl), each after thorough degassing of the
suspensions. After thermal equilibration, aliquots of 3 μl of the NSAID
solution were added every 5 min into the lipid-containing cell, which
was stirred constantly, and the heat of interaction after each injection
measured by the ITC instrument was plotted versus time. The total
heat signal from each experiment was determined as the area under
the individual peaks and plotted versus the [drug]:[lipid] molar ratio.
Since the instrument works in temperature equilibrium at a constant
‘current feedback’ corresponding to a power of approximately 74 μW,
the occurrence of an exothermic reaction leads to a lowering of this
current and of an endothermic reaction to an increase. All titration
measurements, performed at constant temperatures, were repeated at
least 2 times. As control, the drugs were also titrated into pure buffer.
2.5. FRET (Förster resonance energy transfer) spectroscopy
Intercalation of the NSAIDs into phospholipid liposomes composed
of DMPC was determined in 20 mM Hepes, 150 mM NaCl, pH 7.4 at
37 °C by FRET spectroscopy applied as a probe dilution assay [25,26].
The drugswere added to the lipid aggregateswhichwere labelledwith
the donor dye NBD-phosphatidylethanolamine (NBD-PE) and accep-
tor dye Rhodamine-PE. Intercalation was monitored as the increase of
the ratio of the donor ﬂuorescence intensity ID at 531 nm to that of the
acceptor intensity IA at 593 nm (FRET signal) in dependence on time.
3. Results
3.1. Fourier-transform infrared spectroscopy/attenuated total reﬂectance
(FTIR/ATR)
FTIR spectroscopy is most suitable for studying the interactions at
the water lipid interface because this technique provides information
Fig. 1. Infrared ATR spectrum of a 10 mM hydrated ﬁlm of DMPC in HEPES buffer at
pH=7.4 taken at 20 °C. At the top, the chemical structure of DMPC is plotted.
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and its dynamic information from all the regions of the molecule in
one single experiment. Each band of the spectrum has a characteristic
position of the band maximum, denoted by its wavenumber,
absorption maximum and width. If an exogenous molecule interacts
with the phospholipid bilayer the spectroscopic parameters change,
because the vibrational band contours depend on the nature of the
atoms involved and their conformation in aqueous environment.
The infrared spectra of DMPC were analyzed in the following
regions: phosphate asymmetric stretching vibration PO2− (1220–Fig. 2. IR spectra of the asymmetric PO2− stretching region for mixtures of DMPC and the t
mathematical additions of the pure spectra of the compounds, the spectra on bottom are th
[DMPC]:[drug].1260 cm−1), ester carbonyl stretching mode (1680–1800 cm−1) and
the antisymmetric CN+C stretchingmode (ν(CN+)) (950–1000 cm−1).
These groups were selected in the study because they are potential
binding sites (e.g. by electrostatic interaction) or affected by hydration
due to interaction or conformational changes. The symmetric CH2
stretching vibration (2850–2855 cm−1) was analyzed as a parameter
associated with the order (or ﬂuidity) of the acyl chains of the
phospholipids. A complete spectrumof pureDMPCand its characteristic
vibrational bands are shown in Fig. 1.
3.1.1. Phosphate region as a sensor for hydration of phospholipids
The asymmetric stretching vibration of the PO2− moiety νas(PO2−)
has been extensively studied [27–30] as sensor for interactions in the
headgroup region. The νasPO2− band is very sensitive to the hydration
conditions, in that thewavenumber values decrease substantially with
increasing hydration, i.e., they are shifted from 1250 for low hydrated
to 1230 cm−1 for highly hydrated bilayers, caused by the hydrogen-
bonded water molecules to the charged phosphate group [28,29]. For
DMPC both band components are present, one lying at 1227 and one at
1256 cm−1 (see Fig. 1), in accordance to previous result by Pohle et al.
[30]. A shift in the wavenumbers is caused when external molecules
modify the number and orientation of hydrogen bonded water
molecules around the head group as well as changes in the polarity
of the environment.
Fig. 2A–C shows the spectra of three mixtures of DMPC with the
NSAIDs in the region of the νas(PO2−) phosphate vibrations: The ﬁgures
on top are amathematical addition of thepure spectra ofDMPCand the
NSAIDs, the ﬁgures on bottom represent the interacting DMPC:NSAID
mixtures. Therefore, in the case of non-existing interactions between
the compounds both spectra should be identical. As can be seen from
the comparison, the analysis of the bands reveals an interaction of the
three drugs with this lipid group. For example, both bands of the
antisymmetric PO2−mode in the pure DMPC spectrum aremodiﬁed by
the presence of Ibuprofen in that the band intensity corresponding to a
highly hydrated state is reduced while the band intensity from the
band belonging to low hydration is enhanced (Fig. 2A). A similar effect
is observed for the DMPC:Naproxen mixture (Fig. 2B), whereas thehree. NSAIDs, Ibuprofen (A) Naproxen (B), and Diclofenac (C). The spectra on top are
e spectra of the interacting mixtures. All experiments were done at a 1:0.5 molar ratio
Fig. 3. Peak positions of the symmetric stretching vibration bands of the methylene
groups in dependence of temperature. DMPC in the presence of (A) Ibuprofen (B)
Naproxen (C) Diclofenac at -■ 1:0, -○ 1:0.5, -▲ 1:1 and -□ 1:2 molar ratios.
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region (Fig. 2C).
3.1.2. Carbonyl stretching region
The carbonyl stretching vibration of phospholipids CfO group is a
sensitive sensor for the hydration of the lipid interface region, being
sensitive to the hydration state, polarity, degree and nature of the
hydrogen bonding interactions in the lipid–water interface [27,31].
Different hydration of the carbonyl groups leads to the splitting of the
group vibration into two different bands at 1723–1728 cm−1 for the
hydrogen bonded and 1740–1742 cm−1 for the non-hydrogen bonded
CfO group [32]. In Table 1 the results are shown after curve ﬁtting of
the single band components for pure DMPC and the three mixtures of
the lipid with the NSAIDs at a 1:0.5 molar ratio. There is no shift in this
band which gives important evidence that the drug is not interacting
in the carbonyl region, in contrast to the results presented for the
phosphate region. The FTIR transmission datawere also analyzed with
the same conclusion (data not shown).
3.1.3. Amino stretching region
In literature, the interaction of water with the choline groups has
been studied with different phospholipids. A hydrogen bonding
formation between water and the choline group is not possible due
to the positive charge of the nitrogen. However, the choline group is
associated with water molecules by dipole interactions [33], and an
interaction with the NSAIDs could cause a shift in the position of this
vibration because of the negative charge of the drugs. The results of
the analysis via curve ﬁtting in the region of the amino vibrational
band (data not shown) do not reveal any kind of interaction between
the drug and the amino group. These data are indicative for the
absence of a direct interaction between the NSAIDs and this moiety,
i.e. the absence of the drug in this region of the phospholipid.
3.1.4. Symmetric stretching vibration of CH2 groups
Thewavenumber of the peak position of the CH2 band (νsCH2) as a
function of the temperature is a recognized parameter sensitive to
lipid order and packing [21]. Insertion of molecules into the bilayer
increases the space between the fatty acids causing an increase in
their mobility and their frequency. The peak positions of the
methylene stretching modes (νsCH2) in each phase of the lipids
have different values, in the gel phase νs(CH2) lies at 2850 cm−1and
in the liquid crystalline phase around 2852 to 2853 cm−1.
At the main phase transition temperature (Tm) the lipid undergoes
a conversion from the gel phase to the liquid crystalline phase because
of the melting process of the hydrocarbon chain. The Tm has a
characteristic value for each phospholipid depending of the length of
the acyl chains [34] and the structure of the head groups [35]. Fig. 3
shows the temperature dependence of thewavenumbers values of the
peak positions of the DMPC acyl chains for the pure lipid and for the
mixtures, DMPC/NSAIDs, at different molar ratios. The interaction of
the NSAIDs results in a shift in Tm as well as a ﬂuidization of the
system. The strongest change is observed for Diclofenac, for which Tm
is shifted up to ca. 15 °C downwards at a 1:2 molar ratio. At the same
molar ratio, Naproxen induces a shift of ca. 5 °C and Ibuprofen of ca.
7 °C. A slight ﬂuidization of the acyl chains is evident from the increaseTable 1
CfOStretching band vibration after curveﬁtting procedure for DMPCand threemixtures
[DMPC]:[NSAID] at a molar ratio of 1:0.5
Sample CfO Peak position/cm−1
Hydrogen bonded Non-hydrogen bonded
DMPC 1726 1739
DMPC+Ibuprofen 1727 1740
DMPC+Naproxen 1725 1739
DMPC+Diclofenac 1724 1739in the wavenumbers of the νs(CH2) band at ﬁxed temperature, and
might give evidence either for a direct interaction of the drug with the
phospholipids membrane, or only with the pure head group
connected with a change of the lipid packing.
3.2. Differential scanning calorimetry
The calorimetric analysis was performed in order to determine the
heat ﬂow associated with the lipid phase transitions. It can be used to
detect interactions between the NSAIDs and the phospholipid. The
analysis was performed for pure DMPC and for mixtures of DMPC and
the drugs at different molar ratios. The results of the experiments are
shown in Fig. 4A–C. The thermogram for pure DMPC shows two peaks,
Fig. 4. DSC thermograms of DMPC liposomes + in the presence of (A) Ibuprofen (B) Naproxen and (C) Diclofenac. The numbers on the right side represent the different molar ratios
of the mixtures (DMPC:NSAID). DMPC to NSAID molar ratio: 1:0 (top), 1:0.1, 1:0.25, 1:0.5, 1:1, 1:2 (bottom)
Fig. 5. Förster ﬂuorescence resonance energy transfer spectroscopy (FRET) of 0.01 mM
DMPC liposomes at 25 °C with the three NSAIDs: Ibuprofen (dotted line), Naproxen
(dashed line) and Diclofenac (straight line). Every 50 s, 0.5 μl of a stock solution of
0.1 mMNSAIDwas added to 1 ml of liposomes, and the FRET signal ID/IAwas monitored
in dependence on time.
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temperature (ca. 15 °C) (pretransition) corresponds to the transition
from Lβ into the ripple phase (Pβ) and the large peak at higher
temperature (ca. 24 °C) corresponds to the main transition [36]. The
Pβ-phase is one of the gel phases which occurs due to structural
constraints between the packing characteristics of the two acyl chains
and the headgroup [37]. For the three NSAIDs at a 1:0.1 molar ratio the
gel to liquid crystalline main phase transition is still observed but
broadened and shifted to lower temperatures, whereas themetastable
ripple phase disappears. This is in accordance to Lygre et al. [38] andDu
et al. [39].
The three NSAIDs are able to alter the cooperativity of the phase
transition of the phospholipid. Diclofenac has the strongest effect at a
1:2 molar ratio, shifting the Tm to 10 °C. At low molar ratios (1:0.1) a
phase separation occurs. This is especially pronounced for Diclofenac.
At a molar ratio DMPC:Diclofenac of 1:0.5 two phase transitions are
observed with their maxima located at 12 and 18 °C. The phase
separation is dependent on the lipid to Diclofenac ratio. The same
phenomenon of phase separation is obvious for Naproxen at a 1:0.5
molar ratio (Fig. 4B). At higher molar ratios (1:2) the Tm is shifted
below 18–19 °C. Ibuprofen at the same molar ratio shifts the Tm close
to 20 °C and has a broadening effect on the endothermic peak. A clear
phase separation in the presence of Naproxen is not so pronounced as
for the other twoNSAIDs systems. The DSC results are in accordance to
the infrared measurements where the Tm was also shifted to lower
temperature, indicating a strong destabilization of the gel phase. The
DSC results conﬁrm the drug–lipid interaction and association due
to the shift in the peak position of the Tm. With increasing amount
of NSAIDs the phase transition enthalpy of the higher melting
phase (phase composed of mainly pure lipid) decreases, whereas
the phase transition enthalpy of the lower melting phase (phase
containing higher amounts of DMPC-NSAID “complexes”) increases
(see Fig. 4B, C). In contrast to the evident inﬂuence on the phase
transition temperature, however, the overall molar enthalpies of the
transition remain constant at all molar ratios of the NSAIDs:DMPC
mixtures (data not shown). However, it has to be considered, that
the overall phase transition enthalpy is the sum of the phase transition
of the different phases formed. This is especially evident by analyzing
the Diclofenac system. The phase transition enthalpy of the singlephase transition, as observed for example for the system DMPC:
Diclofenac at a molar ratio of 1:0.5, is strongly reduced compared to
the main phase transition enthalpy of the pure lipid. From the DSC
data no information can be derived with regards to the nature of the
formed phases.
3.3. FRET spectroscopy
Förster resonance energy transfer spectroscopy (FRET) was
applied to determine a possible intercalation of the NSAIDs into
DMPC liposomes, by using liposomes ﬂuorescently labelled by NBD-PE
(donor) and RhoPE (acceptor) dyes. The ratio of the donor to acceptor
signal (FRET signal) is a direct measure for an intercalation into the
liposome membrane because of the strong dependence of this signal
(Förster energy transfer) on the distance between the two ﬂuores-
cence markers.
Fig. 6. Isothermal calorimetric titrations at 27 °C of (A) Hepes 20 mM with 30 injections of 3 μl of 10 mM Naproxen and (B) DMPC liposomes 0.05 mM with 30 injections of 3 μl of
2 mM Naproxen.
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below, during and above the phase transition of DMPC, at 15 °C,
25 °C, and 37 °C, respectively. In Fig. 5 ﬁve titrations at equimolar steps
are presented for the three drugs at 25 °C corresponding to molar
ratios of 1:1 up to 1:5 (DMPC:NSAID). The results do not show any
changes of the FRET signal (Idonor/Iacceptor values), which demonstrate
that the drugs are not intercalating into the acyl chains DMPC
liposomes. This, however, does not rule out an interaction with the
head group. The data are similar at 15 °C and 37 °C, showing no
intercalation of the NSAIDs with the lipid moiety independent of the
phase state of DMPC (data not shown).
3.4. Isothermal titration calorimetry
ITC is an invaluable technique used for measuring and characteriz-
ing the thermodynamic of binding interactions. The technique is
based on the detection of heat production by monitoring a reaction
between a molecule and a ligand. When two substances associate and
interact, heat is either generated or absorbed. With ITC it is possible to
measure in one single experiment: binding constants (KB), reaction
stoichiometry (n), enthalpy (ΔH), Gibbs free energy (ΔG) and entropy
(ΔS), thereby providing a complete thermodynamic proﬁle of the
molecular interaction [40]. Further experiments were done below and
above Tm of the phospholipid with the different drugs. The experi-
ments do not show any kind of heat production except from dilution
enthalpy. Exemplary experiments are shown in Fig. 6.
4. Discussion
The investigated NSAIDs are known to represent non-speciﬁc
inhibitors of the cycloxygenase pathway thus suppressing the
formation of inﬂammation mediators such as prostaglandins. The
conversion of arachidonic acid as starting point of this inﬂammation
path is a membrane-bound step and should depend on physical–
chemical properties of the latter and the changes due to drug binding.
In the present paper, the interaction of the NSAID drugs with model
membranes from synthetic lecithin (DMPC) was investigated by
applying a combination of different spectroscopic and thermody-
namic techniques. According to the FTIR–ATR results the drugs are
located preferentially in the polar head groups of the phospholipids.
There is evidence after the analysis of the vibrational bands in the
1300 to 1150 cm−1 spectral range (Fig. 2), that the drugs are locatedclose to the phosphate region. Lichtenberger et al. [41], have suggested
that the anionic groups of the NSAIDs can chemically associate with
the positively charged choline group of PC. The analysis of the
carbonyl and amino vibrations of the choline group of DMPC:NSAID
mixtures did not show a signiﬁcant shift in the observed wavenum-
bers, discarding the possibility of interactions with these moieties. On
the other hand, the spectra changes, or in the case of DMPC:Ibuprofen
and DMPC:Naproxen mixtures, the intensity shifts of the PO2−
asymmetric stretching vibrations in favour of the band corresponding
to low hydration (Fig. 2A), are proofs for the location of the drugs in
this region of the headgroup.
The observed shifts in the PO2− asymmetric vibrations can be
understood as changes in the order of the water molecules in the
hydration shell of the head group. This can be explained by the
presence of a negatively charged group (COO−) of the drug near the
phosphate region of DMPC: These two negative charges may be
bridged by positive counterions, responsible for this (weak) interac-
tion. That such interactions – favoured by the action of counterions –
may take place, were shown in experiments with negatively charged
lipids, which do incorporate into negatively charged, but not into
uncharged liposomes [25,42].
The presence of this charge can compete for the formation of
hydrogen bonds with the water molecules of the hydration shell,
which is an entropy-driven process, also in accordance with the ITC
results that exclude enthalpic contributions of the reaction.
The analysis of the phase transition behaviour also reveals an
interaction of the NSAIDs with the DMPC molecules. In the gel phase
below Tm, the mobility of the hydrocarbon chains is low, whereas the
liquid crystalline phase is characterized by disordered lipid chains.
During the phase transition, there is an increase in the entropy with
chain rotational disorder, together with an increase in the inter-
molecular entropy and an increase in the head group hydration. The
van der Waals attraction between the chains is reduced, and there is
an increase in the exposure of the acyl chains to the polar–apolar
interface. The phase transitions at Tm take place when the entropic
contributions balance the enthalpic ones in the transition process. If
an exogenous molecule is capable of inducing a perturbation in the
bilayer, the thermodynamics parameters related to the phase
transition are changed and the consequence is a shift in Tm. A shift
of the wavenumber of the CH2 symmetric vibration is closely related
to the degree of order of the acyl chains. The infrared results show that
the three drugs shift the Tm to lower temperatures, indicating a strong
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alteration of the hydration of the lipid headgroups and thus
headgroup–headgroup interactions, which leads to changes in the
packing density in the headgroup region. Previous studies have also
suggested that the NSAIDs are able to locate near the headgroup of
DPPC molecules with the capability to form hydrogen bonding with
the water molecules or the headgroup itself [26]. It is known that the
DPPC headgroup is inclined thus allowing an interaction with the
phosphates but not with the amine N+-Me3 group. The observed
weakening of the water binding to the phosphate region modiﬁes the
membrane afﬁnity for water and the packing of the bilayers, leading to
a change in the composition of the aqueous phase, and the equation
ΔTt=ΔGt/ΔSt demonstrates the relation between the shift in Tm and
the entropy of thewatermolecules of the hydration in the bilayer [43].
Another phenomenon important to analyze is the increase of the
net surface charges. The three drugs are negatively charged. The
presence of these molecules in the polar region is modifying the
electrostatic properties of the phospholipids, which could explain the
shifts in the Tm of DMPC as a concentration-dependent perturbation.
All these interactions inﬂuence the lipid bilayer structure and of
course the lipid phase behaviour. The three NSAIDs induce a change in
the sharpness of the phase transition peak as measured by DSC,
caused by broadening of the phase transition temperature range (Fig.
4), indicating that the NSAIDs cause a destabilization of the
phospholipid intermolecular cooperativity. This property is related
with the number of acyl chains that are able to convert from the gel to
liquid crystalline phase and reﬂect the high degree of aggregation in
these systems. The DMPC:Ibuprofen:Naproxen systems undergo a
small shift in the Tm and a broadening of the phase transition peak.
Furthermore, the latter and the DMPC:Diclofenac system show also a
phase separationwhich results in the presence of a second peak in the
DSC thermograms (Fig. 4B, C). The presence of another phase is
probable due to the induction of domains by the NSAIDs. Diclofenac
induces a higher decrease in Tm in comparison with the other two
NSAIDs and also a clear phase separation. As the overall ΔH value does
not change, it indicates that the NSAIDs are located at the water/lipid
interphase. The location of the drugs in the polar head groups in some
way generates a reorganization of water molecules affecting the
cooperativity of the phospholipid. In the case of Diclofenac, the
reorganization must be higher to explain the strong shift in the Tm
value. This destabilization is directly related to the increasing drug
concentration, indicating further reorganization of water molecules in
the head group region with the increase in NSAID concentration. Tm
depends to a certain extent on the structure of the polar head groups;
therefore the NSAIDs induce changes in the packing of the polar head
group region, by modifying the surface-bond water molecules in the
bilayer. The number of water molecules within the phospholipid
liposomes is a determinant for the functions of the bilayer in an
aqueous environment.
The lack of interaction found in the FRET experiments (Fig. 5) is in
accordance to the ITC data showing no enthalpic reaction of the drug:
lipid complex (Fig. 6). These ﬁndings are also consistent with the DSC
results: The constant phase transition enthalpy implies that the
NSAIDs do not intercalate into the acyl chain region of the bilayer, but
are adsorbed at the lipid–water interface, inﬂuencing the ordered
water layer at the polar interface. These conclusions are compatible
with previous studies of other research groups. Castelli and coworkers
found that the acid form of Naproxen, covalently linked to a water-
soluble polymer, induces a shift in the Tm of DPPC [44] and DMPC [45]
liposomes without variations in the enthalpy. The Gibbs energy of
binding is dictated by Ka=e−ΔG/RT, however, ΔG depends on two
different parameters, ΔG=ΔH−TΔS, which contribute to the process.
In case of a dominant electrostatic interaction between amolecule and
its ligand, the enthalpy contribution is higher than the entropy one. As
the experiments did not detect any kind of enthalpic contribution, it
can be concluded that the interactions between the phospholipid andthe NSAIDs are mediated only by entropic processes. Taking into
account that the interaction of the three drugs with the phosphate
group is similar, it is important to check the structural similarities in
the three NSAIDs. The COO− moiety in the drugs is the common
feature. It is well known that the phosphate group is sensitive to
hydration alterations inmembranes. The hydrationplays an important
role in the stability of the bilayer. The alterations of the hydration shell
have consequences for the membrane, like changes in the semi-
permeable properties, rate and efﬁciency of the cell growth and
modulate the activity of a variety of membrane-associated enzymes.
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